Medication Therapy Management (MTM) software is evolving from meeting minimum CMS requirements to leveraging AI and structured data integration for higher efficiency, improved patient outcomes, and ...

The integration aims to ensure planning is based on real-world clinical developments, uniting internal and external insights.

Many private-credit fund managers are playing down their exposure to software as fears spread about threats from artificial intelligence. A detailed analysis revealed four large funds marketed to ...

Software firm Planview Inc. has reached out to private credit firms to help it address debt maturing next year, according to people familiar with the situation. Increased competition due the ...

Planview IdeaPlace is an enterprise innovation and ideation management platform designed to capture, evaluate, and advance ideas at scale. It enables organizations to engage employees and external ...

Major software stocks like Microsoft, Oracle, and Salesforce have seen significant declines from their recent highs. Analysts are divided on whether the selloff is due to fears that AI will make ...

Software stocks have been hammered as fears of AI proliferation take hold. This provides a compelling opportunity for savvy investors. By Danny Vena, CPA – Feb 14, 2026 at 3:02AM EST AI start-up ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Planview, the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), today announced Connected Work Graph, dependency intelligence that leverages ...

Providing real-time visibility and insights into cross-organizational work, Connected Work Graph turns invisible dependencies into clear action. Planview, the leading end-to-end platform for Strategic ...

New AI tools from Anthropic sparked a broad sell-off in software and data stocks. Executives say fears are overblown, but analysts warn of margin and pricing pressure. Investors are reassessing which ...